secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2022-03-15T23:59:59+00:00
Accession:  0001104659-22-033912
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Esperion CFO Richard Bartram to step down effective April 8, 2022
-----------------------------------------------------------------

- CFO, Principal Financial Officer and Principal Accounting Officer Richard B. Bartram departing.
- Departure effective April 8, 2022; no successor named in filing.
- Decision not due to any disagreement with company operations, policies or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/0001104659-22-033912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/tm229356d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-033912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer